Shue Youe Kong 4
4 · OPTIMER PHARMACEUTICALS INC · Filed Nov 17, 2011
Insider Transaction Report
Form 4
Shue Youe Kong
VP, clinical Development
Transactions
- Other
Common stock
2011-11-15$9.72/sh+1,186$11,533→ 94,230 total
Footnotes (1)
- [F1]Acquired under the Company's employee stock purchase plan on November 15, 2011.